3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
12
Multiple Myeloma
11
Lymphoma
10
Neoplasm Metastasis
9
Melanoma
7
Leukemia, Myeloid, Acute
7
Prostatic Neoplasms
6
Neuroblastoma
6
Carcinoma, Non-Small-Cell Lung
6
Wilms Tumor
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Fallopian Tube Neoplasms
5
Burkitt Lymphoma
5
Breast Neoplasms
5
Triple Negative Breast Neoplasms
4
Small Cell Lung Carcinoma
4
Rhabdoid Tumor
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Osteosarcoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Histiocytosis, Langerhans-Cell
4
Hepatoblastoma
4
Glioma
4
Ependymoma
4
Central Nervous System Neoplasms
4
Sarcoma, Kaposi
3
Sarcoma
3
Interventions
Paclitaxel
6
Carboplatin
6
Gemcitabine
3
pembrolizumab
2
Irinotecan
2
Erlotinib Hydrochloride
2
Capecitabine
2
Bevacizumab
2
sintilimab
1
pertuzumab
1
pemigatinib
1
olaparib
1
ivosidenib
1
ipatasertib
1
etoposide phosphate
1
erythromycin propionate-N-acetylcysteinate
1
entrectinib
1
cobimetinib
1
belinostat
1
atezolizumab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
alectinib
1
Vemurafenib
1
Surveys and Questionnaires
1
Oxaliplatin
1
HhAntag691
1
Everolimus
1
Etoposide
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Unknown Primary
×
Specimen Handling
×
Clear all
No trials found.